Drawing for LINEARIS

USPTO serial 79404811

LINEARIS

Reviewed by CopyMark Law Group

Reg. 8237375Status 700Registered
Filing date
Status date
Registration date
May 5, 2026
Examiner
SEVERSON, JUSTIN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LINEARIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter S. Weissman

Peter S. Weissman Blank Rome LLP1825 Eye Street NWWashington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
044Providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of diabetes test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of antimicrobial resistance test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis; providing medical information in the treatment and prevention of metabolic diseases and disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing cancer screening services; diabetes screening services; medical screening services relating to cardiovascular disease; medical screening services relating to metabolomic diseases; providing information in the field of general health and wellness via a website; providing information relating to health and wellness, namely, diabetes; genomic medical analysis services for cancer diagnostic purposes provided by medical laboratories and for treatment monitoring purposes to measure toxicity of treatment and response of treatment; proteomic and metabolomics medical analysis services for diabetes and antimicrobial resistance, diagnosis and treatment; medical screening; providing information relating to the preparation and dispensing of medications; pharmaceutical and drug review services of others in the nature of information relating to pharmaceutical and drug treatments and the toxicity of such treatments for diagnostic purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories using diagnostic biomarkers for use in assessment of genomic, proteomic and metabolomics analysis for scientific, education and clinical use; remote monitoring of medical data for medical diagnosis and treatment; analysis and processing of blood plasma, stem cells, red blood cells, white blood cells, blood platelets and urine being medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 14, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 13, 2026FIMPFINAL DISPOSITION PROCESSED—
Oct 13, 2026LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Aug 5, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 5, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 5, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 23, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 23, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 23, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 9, 2025RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Dec 9, 2025RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Dec 9, 2025RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Nov 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 4, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 4, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 4, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 13, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 13, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 14, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 14, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 7, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2024DOCKASSIGNED TO EXAMINER—
Sep 23, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 23, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance